Parkinson’s Disease

The latest from Cogstate, leaders in optimizing the measurement of cognition

Study Finds Use of Nicotinic Alpha-7 Agonist Improves Cognitive Function In Parkinson’s Patients

March 24, 2016

For patients diagnosed with Parkinson’s disease (PD), the need to balance effective treatments with their unpleasant side effects is an ongoing battle. Long considered the gold standard for treating early symptoms of PD, levodopa (L-DOPA) is able to cross the blood-brain barrier to produce dopamine in the brain which helps manage the symptoms of motor […]